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Phosphatidylinositol transfer proteins (PITPs) regulate the interface between signal transduction,
membrane-trafficking, and lipid metabolic pathways in eukaryotic cells. The best characterized
mammalian PITPs are PITP and PITP, two highly homologous proteins that are encoded by
distinct genes. Insights into PITP and PITP function in mammalian systems have been gleaned
exclusively from cell-free or permeabilized cell reconstitution and resolution studies. Herein, we
report for the first time the use of genetic approaches to directly address the physiological
functions of PITP and PITP in murine cells. Contrary to expectations, we find that ablation of
PITP function in murine cells fails to compromise growth and has no significant consequence for
bulk phospholipid metabolism. Moreover, the data show that PITP does not play an obvious role
in any of the cellular activities where it has been reconstituted as an essential stimulatory factor.
These activities include protein trafficking through the constitutive secretory pathway, endocytic
pathway function, biogenesis of mast cell dense core secretory granules, and the agonist-induced
fusion of dense core secretory granules to the mast cell plasma membrane. Finally, the data
demonstrate that PITP-deficient cells not only retain their responsiveness to bulk growth factor
stimulation but also retain their pluripotency. In contrast, we were unable to evict both PITP
alleles from murine cells and show that PITP deficiency results in catastrophic failure early in
murine embryonic development. We suggest that PITP is an essential housekeeping PITP in
murine cells, whereas PITP plays a far more specialized function in mammals than that indicated
by in vitro systems that show PITP dependence.
INTRODUCTION
Phosphatidylinositol transfer proteins (PITPs) are operation-
ally defined by their ability to catalyze the transfer phospha-
tidylinositol (PtdIns) or phosphatidylcholine (PtdCho)
monomers between membrane bilayers in vitro (Cleves et
al., 1991a; Wirtz, 1991). Both yeast and metazoan PITPs
contain one phospholipid-binding site that exhibits a dual
headgroup specificity (Sha et al., 1998; Phillips et al., 1999;
Yoder et al., 2001). Thus, PITPs accomodate two dissimilar
phospholipid substrates in a mutually exclusive binding
reaction.
From a biological perspective, little is known about the
genuine physiological functions of PITPs. The best-studied
case is in yeast where PITP function has been subjected to
genetic analysis. Sec14p, the major yeast PITP, is essential for
protein transport from the Golgi complex (Bankaitis et al.,
1989, 1990). A dissection of how Sec14p translates PtdIns/
PtdCho transfer activity into biological function is driven by
analyses of mutations that relieve cells of the essential
Sec14p requirement for Golgi function and cell viability
(Cleves et al., 1989, 1991b; Fang et al., 1996; Kearns et al., 1997;
Rivas et al., 1999; Li et al., 2000; Xie et al., 2001). Such “bypass
Sec14p” mutants identify novel interfaces between Golgi
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function, lipid metabolism, and the actions of novel proteins
whose functions are only now beginning to be understood.
Precise execution points for individual PITPs in mammalian
cells remain unknown, although reduced PITP function
leads to specific neurodegenerative defects in flies and in the
vibrator mouse (Hamilton et al., 1997; Milligan et al., 1997).
There are at least three soluble mammalian PITPs and
these are designated PITP, PITP, and rdgB (Dickeson et
al., 1989; Tanaka and Hosaka, 1994; Fullwood et al., 1999).
The best characterized of these are PITP and PITP. These
two isoforms share 77% sequence identity and are encoded
by distinct genes. PITP is distinguished from PITP in that
it catalyzes the in vitro transfer of PtdIns, PtdCho, and
sphingomyelin (SM), whereas PITP is unable to catalyze
SM transfer (van Tiel et al., 2000). PITP reconstitutes as a
cytosolic factor required for 1) Ca2-activated discharge of
secretory granule cargo in permeabilized neuroendocrine
cells (Hay and Martin, 1993), 2) budding of both constitutive
secretory vesicles and immature secretory granules from the
trans-Golgi network of neuroendocrine cells (Ohashi et al.,
1995), 3) budding of constitutive secretory vesicles from
hepatocyte trans-Golgi network (Jones et al., 1998), and 4)
hydrolysis of phosphatidylinositol bisphosphate mediated
by various G protein-coupled phospholipase C isoforms
(Cunningham et al., 1996). The former two reconstitution
systems implicate a role for mammalian PITP in regulation
of vesicle trafficking, an activity analogous to Sec14p func-
tion in yeast.
In all of these in vitro systems, PITPs stimulate the syn-
thesis of various phosphoinositides that play critical roles in
facilitating the reactions that are being reconstituted. More-
over, PITP and yeast Sec14p can fully replace PITP in each
of these reconstituted reactions. This is a rather remarkable
result given that yeast Sec14p and mammalian PITPs share
no primary sequence homology nor structural similarity at
all (Skinner et al., 1993; Sha et al., 1998; Yoder et al., 2001). Yet,
the interchangeability of PITPs in the reconstituted in vitro
systems is significantly at odds with the results of biological
experiments. Saccharomyces cerevisiae expresses five distinct
Sec14p-like PITPs, but none of these PITPs shares perfect
physiological redundancy with the others, and each regu-
lates a distinct step in phospholipid metabolism (Li et al.,
2000; Wu et al., 2000). Moreover, mammalian PITP exerts
potent dominant-negative effects when expressed in lieu of a
homologous Drosophila PITP that harbors the same biochem-
ical properties as does PITP in vitro (Milligan et al., 1997).
These data strongly suggest that individual mammalian
PITPs also execute specific in vivo functions. Furthermore,
these data indicate that the physiological specificity of mam-
malian PITPs is unavailable for experimental scrutiny in
present in vitro systems.
In this report, we describe our use of genetic approaches
to gain insight into the physiological functions of PITP and
PITP in murine cells. Our data clearly indicate that disrup-
tion of both copies of the PITP structural gene in murine
cells fails to compromise their growth or vigor, and that
ablation of PITP function has no significant effect on bulk
phosphoinositide or phospholipid metabolism. Moreover,
PITP / cells are competent for protein trafficking
through the constitutive secretory pathway, are normal with
regard to endocytic pathway function, are fully competent
for both biogenesis and agonist-induced exocytosis of dense
core secretory granules (DSGs), are responsive to bulk
growth factor stimulation, and retain their pluripotency.
Thus, PITP does not uniquely execute an essential house-
keeping function in murine embryonic stem (ES) cells. In
contrast, we were unable to evict both PITP alleles from
murine ES cells, and we demonstrate that PITP deficiency
leads to early failure in murine embryonic development. We
suggest that PITP is an essential housekeeping PITP in
murine cells, whereas PITP plays a far more specialized
function in mammals than what is indicated by in vitro
systems that demonstrate PITP dependence.
MATERIALS AND METHODS
Cell Culture and Antibodies
R1 and AB1 ES cell lines have been described (McMahon and
Bradley, 1990; Nagy et al., 1993) and were maintained in standard
media consisting of DMEM (4.5 g/l glucose), 1 mM sodium pyru-
vate, 1 nonessential amino acids, 2 mM l-glutamine, a 50-g/ml
penicillin/streptomycin cocktail, 15% fetal bovine serum (Invitro-
gen, Carlsbad, CA), 2-mercaptoethanol, and leukemia inhibitory
factor (LIF). Media used for differentiating ES cells to embryoid
bodies were identical except LIF and 2-mercaptoethanol were omit-
ted. ES cells were plated on feeder layers consisting of either mito-
mycin C-treated murine embryonic fibroblast feeder cells or gelatin-
coated tissue culture dishes. When necessary, cells were dispersed
with a 0.25% trypsin/0.1% EDTA solution.
Isolation of Genomic PITP and PITP Clones
A mouse 129SVJ genomic -phage library was screened by standard
filter-lift plaque hybridization methods by using random primed
32P-radiolabeled rat PITP or PITP cDNAs as probes. Hybridized
filters were washed in 2 SSPE, 0.5% SDS at room temperature
followed by two washes in 0.2 SSPE, 0.5% SDS at 65°C. From such
screens, -phage clones containing 12- and 15-kb genomic insert
fragments of PITP and PITP were recovered. Iterative cycles of
physical mapping and nucleotide sequence analysis confirmed the
identities of the genomic fragments, and identified the precise na-
ture and physical positions of the exons contained in each genomic
fragment.
Transfection and Selection of ES Cell Recombinants
All experiments were carried out with ES cells grown on embryonic
murine fibroblast feeder cells. For electroporation, ES cells (80%
confluence) were harvested by trypsinization, centrifuged through
culture medium, and resuspended in fresh culture media. A 20-g
load of linearized targeting vector was electroporated into 2  107
cells via a single discharge (300 V, 250 F) delivered by a single cell
electroporator (Bio-Rad, Hercules, CA). Immediately after electro-
poration the cells were distributed onto 100-mm embryonic mouse
fibroblast feeder plates and allowed to recover for 24 h before
challenge with 0.5 mg/ml G418 and 2 mM gangcyclovir. Selection
media were exchanged every 3–4 d, for a total of 12 d, after which
individual colonies were picked and expanded.
DNA Hybridization
DNA from each clonal ES cell line was prepared using the Wizard
genomic DNA purification kit marketed by Promega (Madison, WI).
Purified DNA (10 g) was subsequently digested with either EcoRI
or XbaI, electrophoresed through a 1% agarose gel, transferred to
Hybond N nylon membrane (Amersham Biosciences, Piscataway,
NJ), and hybridized with probe 1 (Figure 1A) under stringent non-
aqueous conditions (Southern, 1975). Hybridized products were
washed at 68°C in 1 SSC/0.1% SDS and 0.2 SSC/0.1% SDS.
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Quantitative Enzyme-linked Immunosorbent Assay
(ELISA)
Total ES cell protein (20 g) or 50 and 100 ng of PITP C-terminal
peptide was affixed onto coated ELISA plates (Falcon Plastics, Ox-
nard, CA) by baking overnight at 60°C. Wells were incubated with
0.5% Tween 20 in phosphate-buffered saline (PBS) (30 min at 37°C),
flushed three times with PBS, and blocked with 2% bovine serum
albumin (BSA) for 90 min at 37°C. PITP-specific rabbit polyclonal
antibody was added to wells and incubated at 37°C for 3 h. After
extensive washing with PBS, secondary goat anti-chicken antibody
was added to wells, incubated at 37°C for 3 h, and again washed
with PBS. ELISA signal was developed with the OPD reagent sys-
tem marketed by Sigma (St. Louis, MO). Signal was quantified as
absorbance at 405 nm by using a Biospec Products plate reader.
Lipid Chromatography
ES cells were plated onto 100-mm tissue culture dishes at a density
of 1  106 cells/plate and labeled in standard media containing 10
Ci/ml of [3H]inositol and supplemented with serum (final con-
centration of 15%) dialyzed to remove all serum components with
molecular mass of 1000 Da. After 72 h, cells were harvested by
washing in cold PBS followed by scraping into glass tubes. Samples
were then extracted with 1.88 ml of CHCl3/methanol/HCl and
incubated for 10 min on ice. Subsequently, 0.625 ml of CHCl3 and
0.625 ml of 0.1 M HCl were sequentially added, and the phases
separated by centrifugation for 10 min at 160  g. The organic phase
was collected and dried under a stream of nitrogen gas. Samples
were resuspended in a small volume of CHCl3 and loaded onto a
dried silica gel 60 thin layer chromatography (TLC) plate and re-
solved in a CHCl3/methanol/H2O/concentrated ammonia (48:40:
7:5) solvent system. The TLC plates were exposed to film, inositol
lipid species were identified, and individual species were quantified
by scraping from the TLC plate and scintillation counting.
SM, PtdCho, and water-soluble choline metabolite analyses were
performed by plating and ES cells as described above with the
exception that cells were radiolabeled with 1.5 Ci/ml of [14C]cho-
line chloride. Cells were subsequently washed in ice-cold PBS and
scraped off the plates into 1 ml of 5% trichloroacetic acid. Cells were
pelleted, washed in PBS, resuspended in 1 ml of polar extraction
solvent (15 ml of H2O/15 ml of 95% ethanol/5 ml of diethylether/1
ml of pyridine/36 l of NH4OH/75 l of 5% butylated hydroxy-
toluene in CHCl3/MeOH [2:1]), and incubated at 60°C for 20 min.
Subsequently, 0.5 ml of H2O and 5 ml of CHCl3/methanol/buty-
lated hydroxytoluene (2:1:0.005) were added to the samples and the
mixtures were incubated at 4°C for 60 min. Samples were centri-
fuged for 5 min at 160  g to separate the aqueous (choline,
phosphorylcholine, and cytidine-diphosphocholine-choline [CDP]–
containing) and organic (PtdCho- and SM-containing) phases. These
phases were individually collected and evaporated to dryness un-
der nitrogen gas.
SM and PtdCho were further fractionated by deacylation of Ptd-
Cho upon addition of 0.1 N KOH to the lipid film, and incubation
at 37°C for 1 h. After addition of CHCl3/balanced salt solution/
EDTA, the organic (SM-containing) and aqueous (PtdCho-derived,
glycerophosphocholine-containing) phases were collected and
dried. SM was resolved on silica gel TLC plates with a CHCl3/
methanol (1:1) solvent system. Water-soluble choline metabolites
were separated on silica gel TLC plates by using a methanol/
aqueous 0.5% NaCl/NH4OH (100:100:4) solvent system. Individual
choline-containing species were detected by autoradiography and
quantified by scraping and scintillation counting.
Ratiometric Calcium Measurements
ES cells were grown on feeder layers in 100-mm dishes to 80%
confluence in complete media, seeded onto gelatinized coverslips at
a very low cell density, and allowed to grow for 14 h. Cells were
incubated in serum-free media for 2 h before loading in saline
solution with fura 2-acetoxymethylester (Teflabs, Austin, TX) for 40
min at a final concentration of 5 M fura (Manning and Sontheimer,
1997). Cells were transferred to a Series 20 Microperfusion chamber
on the stage of a Nikon Diaphot 200 inverted epifluorescence mi-
croscope and kept under constant perfusion with HEPES buffer
supplemented with 2 mM Ca2. Immediately before stimulation the
Figure 1. (A) Strategy for targeting of the PITP locus. An HSV-tk
expression cassette from pPNT (Tybulewicz et al., 1991) was engi-
neered so that it flanks a 12-kb mouse genomic PITP clone brack-
eted by SstI restriction sites. A 0.4-kb DNA fragment was released
from the extreme 3 end of the genomic insert so that it is not
represented in the targeting vector. This fragment was subsequently
used as a diagnostic probe, designated probe 1, in Southern hybrid-
ization analyses. PITP exons 8–10 were exchanged for a selectable
neo expression cassette derived by polymerase chain reaction from
pMC1NEO (Stratagene, La Jolla, CA). As described in the text, this
amplified cassette contains an uncharacterized mutation that atten-
uates, but does not abolish, activity of the gene product. (B) Iden-
tification of targeted ES cell clones by Southern hybridization. The
PITP-targeting vector was linearized, introduced into ES cells by
electroporation, and recombinants were selected on the basis of
acquired resistance to G418 and gangcyclovir (see MATERIALS
AND METHODS). Genomic DNA was prepared from / controls
and candidate targeted (/) ES cells, digested to completion with
either restriction endonuclease EcoRI or XbaI (as indicated at bot-
tom), transferred to nitrocellulose, and hybridized with radiola-
beled probe generated by random priming of probe 1 DNA. Diag-
nostic signatures of the wild-type () and targeted () PITP alleles
are indicated at right. Approximately 5% of total R1- and AB1-
derived recombinants exhibited physical signatures consistent with
one wild-type and one targeted PITP allele as shown.
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chamber was flushed with Ca2-free HEPES buffer and cells were
stimulated with serum (3 or 10%) or LPA. Fura was alternately
excited at 340 and 380 nm with a single-wavelength monochromator
and fluorescence ratio obtained every 6 s. Emitted fluorescence
520 nm was captured with an intensified charge-coupled device
camera, digitized, and analyzed using ImageMASTER software.
The ratio of the two images (340/380 nm) was calculated and
converted to absolute calcium concentrations (Grynkiewicz et al.,
1985).
Transferrin Receptor (TfR) Recycling
Steady-state distribution of TfR at 37°C was performed by the
method of Odorizzi et al. (1994). Cells were plated in triplicate wells
(24-well plate) and 24 h later incubated first in serum-free media for
1 h then with 4-g/ml 125I-transferrin (Tf) in 0.1% BSA in PBS for 1 h
at 37°C. The labeling media were removed, the cells rinsed three
times in 0.1% BSA in PBS, and cells were then washed twice for 3
min with 0.5 ml of 0.2 M acetic acid, 0.5 M NaCl, pH 2.4, to remove
surface-bound 125I-Tf. Cells were lysed with 0.1 M NaOH to monitor
intracellular 125I-Tf. Radioactivity in the acid washes and the cell
lysates was quantified and a ratio obtained.
Internalization assays used the IN/SUR method (Wiley and Cun-
ningham, 1982; Kang et al. 1998). Externalization assays have been
described (Jing et al., 1990).
Generation of Mast Cells
ES cells were cultured (10% CO2 atmosphere) on gelatin-coated
culture dishes for 48 h in Iscove’s modified Dulbecco’s medium
(IMDM) with 15% fetal bovine serum (Invitrogen), 1 mM sodium
pyruvate, 0.1 mM nonessential amino acids, 2 mM l-glutamine, 100
U/ml penicillin, 100 U/ml streptomycin, 100 M monothioglycerol,
and 10 ng/ml LIF. Cells were harvested using trypsin-EDTA and
resuspended as single cells in IMDM.
Cells were seeded in methylcellulose-based medium (Stem Cell
Technologies (Vancouver, British Columbia, Canada), supple-
mented as described above but without LIF and containing 40
ng/ml murine stem cell factor, at a density of 500 cells/ml (phase 1
medium) and cultured for up to 21 d. At various times after day 5,
the embryoid bodies were disrupted using 0.5% collagenase (Sigma
Chemical) and the cell suspension was passed through a 21-gauge
needle three times. The hematopoietic progenitors were reseeded in
methylcellulose medium supplemented as before but also including
1% BSA, 10 g/ml insulin, 200 g/ml transferrin, 30 ng/ml murine
interleukin-3, and 30 ng/ml human interleukin-6 (phase 2 medium).
Cultures were maintained for up to 40 d and were fed weekly with
the same medium. At various times, cultures were scored for sur-
face FcRI by using fluorescein isothiocyanate (FITC)-labeled mouse
IgE and for morphology by electron microscopy.
IgE Labeling and Fluorescence-activated Cell Sorting
(FACS) Analysis
Cells were harvested from methylcellulose cultures and treated
with collagenase as described above to obtain a single cell suspen-
sion. Cells were “rested” for 12 h in IMDM supplemented with 5%
fetal bovine serum, 1 mM sodium pyruvate, 0.1 mM nonessential
amino acids, 2 mM l-glutamine, 100 U/ml penicillin, 100 U/ml
streptomycin, and 100 M monothioglycerol. FITC-labeled IgE (gift
of B. Wilson, University of New Mexico, Albuquerque, NM) was
applied to cells (final concentration 5 nM). After 4 h, cells were
collected and fixed. FACS analysis was performed on BD FACSCali-
bur and Coulter Epics Elite instruments.
Regulated Exocytosis Measurements
Permeabilized Cells. Calcium/EGTA buffers were prepared by mix-
ing solutions, made up at identical concentrations adjusted to pH
6.8, of EGTA and endpoint-titrated Ca-EGTA (Gomperts and
Tatham, 1993). Cells, suspended in an iso-osmotic salts buffer solu-
tion [137 mM NaCl, 2.47 mM KCl, 1 mM MgCl2, 20 mM piperazine-
N,N-bis(2-ethanesulfonic acid), pH 6.8] supplemented with 1
mg/ml BSA, were then incubated with metabolic inhibitors (0.6 mM
2-deoxyglucose and 10 M antimycin A) for 5 min (37°C) and
cooled on ice. Streptolysin O (SLO, final concentration 1.6 IU/ml in
the same buffer) was then added. After 5 min, unbound SLO was
washed away by dilution and centrifugation. Rundown was initi-
ated by transferring cells to prewarmed (37°C) iso-osmotic buffer
supplemented with 0.3 mM Ca-EGTA (to regulate pCa8) and 1 mM
MgATP in wells of 96-microtiter plates. Cell load was 10,000/well.
After allowing predetermined times for rundown, the cells were
stimulated to secrete by adding prewarmed solutions containing
Ca-EGTA buffer (3 mM final) formulated to regulate pCa5 (or pCa7
as control) and guanosine-5-O-(3-thio)triphosphate to a final con-
centration of 100 M. After 10 min, the incubations were quenched
by addition of an equal volume of ice-cold iso-osmotic buffer sup-
plemented with 5 mM EGTA. The cells were sedimented by cen-
trifugation and the supernatants sampled for secreted hexosamini-
dase as described (Gomperts and Tatham, 1993; Pinxteren et al.,
1998). Secretion is expressed as percentage of total hexosaminidase
released relative to total content release evoked by cell permeabili-
zation with 0.2% Triton X-100.
Intact Cells. Cells were harvested from methylcellulose cultures,
treated with collagenase, rested as described above, transferred to
fresh IMDM (supplemented as described above) containing 1 or 10
g/ml antidinitrophenol (DNP) IgE (Sigma Chemical), and incu-
bated for 4 h under standard conditions (Buckley and Coleman,
1992). After three washes in PBS (with Ca2 and Mg2) 1% BSA,
cells were transferred to 96-well microtiter plates. Human serum
albumin conjugated to dinitrophenol (Sigma Chemical) was applied
at 0, 1, 10, or 100 g/ml. Cells were incubated (30 min, 37°C),
pelleted, and sampled as described above.
Preparation of Mast Cells for Electron Microscopy
Mast cells were washed in PBS and placed in primary fixative
consisting of 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 2 h
at 4°C. Cells were rinsed three times in 0.1 M cacodylate buffer for
5 min and incubated in 1% osmium tetroxide for 1 h. After three
rinses with 0.1 M cacodylate cells were stained in 0.5% tannic acid
for 10 min.
Before embedding, cells were rinsed three times with 0.1 M
cacodylate buffer, two times with water, and dehydrated by serial
5-min incubations in 50, 75, and 95% ethanol followed by three
5-min incubations in 100% ethanol. Samples were infiltrated over-
night in a 1:1 mixture of ethanol/Spurr’s resin followed by incuba-
tion in 100% Spurr’s resin for 2 h. Samples were finally polymerized
in fresh resin by overnight incubation at 60°C. Thin sections were
prepared and stained with alcoholic uranyl acetate and Reynold’s
lead citrate before imaging by electron microscopy.
RESULTS
Targeting of PITP Mutation into Murine
Embryonic Stem Cell Genome
Data from permeabilized cell systems suggest that PITP
plays critical roles in a number of constitutive and regulated
membrane trafficking events, and in the optimal activation
of signaling pathways that involve G protein-coupled recep-
tors (Cunningham et al., 1996). We therefore expected that
PITP would be essential for the viability of eukaryotic cells.
To test this prediction, we used homologous gene targeting
methods to assess the cellular consequences of loss of PITP
function. To this end, we recovered a 12-kb fragment of
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genomic DNA derived from a 129SVJ mouse strain (see
MATERIALS AND METHODS). As diagrammed in Figure
1A, this genomic fragment harbors exons 7–10 of the PITP
gene. These exons collectively encode amino acids 126–257
of the 278-residue PITP polypeptide. From this genomic
DNA, we constructed a homologous recombination vector
carrying a mutant PITP allele where exons 8–10 are re-
placed with a neo cassette (Figure 1A). This mutation
(PITP::neo) deletes amino acid residues 162–257 from
PITP, and we previously established that this region of the
protein is critical for PITP activity (Alb et al., 1995). In the
targeting vector, a total of 9 kb of PITP genomic flanking
sequences is available for directing replacement of a wild-
type PITP allele by PITP::neo via homologous recom-
bination.
The targeting vector was linearized by restriction in the
vector backbone and introduced by electroporation into ES
cell lines derived from R1 and AB1 mouse strains (see MA-
TERIALS AND METHODS). Recombinants were selected
using a positive-negative selection strategy of dual resis-
tance to neomycin and gangcyclovir (Mansour et al., 1988).
In these experiments, 120 and 76 clones derived from R1 and
AB1 ES cells, respectively, survived the double selection and
were screened for legitimate recombination events. The
screening procedure used Southern hybridization to moni-
tor the genomic arrangement of sequences flanking both
ends of the integrated PITP::neo allele. These analyses
demonstrated that six and three clones derived from paren-
tal R1 and AB1 ES cell lines, respectively, exhibited the
signatures of PITP::neo/ heterozygotes (Figure 1B).
These data indicate a targeting efficiency at the PITP locus
of 5%.
PITP Is Nonessential for Viability of Murine
Embryonic Stem Cells
The neo cassette used to generate the PITP::neo allele
contains a missense mutation that reduces the activity of the
neomycin acetyltransferase gene product such that a single
genomic copy of the neo cassette supports only low-level
resistance to 400 g/ml G418. Two or more genomic copies
of the neo cassette, however, endow cells with resistance to
high concentrations of G418 (2 mg/ml). This property of
neo offers a facile method for generating PITP / ES cell
Figure 2. (A) Genetic diagnosis of PITP / clones. R1- and
AB-1–derived PITP / ES cells were challenged with 2 mg/ml
G418 and surviving clones were isolated. Genomic DNA was pre-
pared from / ES cell controls and high G418-resistant ES cell
clones and analyzed as detailed in Figure 1B. Diagnostic signatures
of the wild-type () and targeted () PITP alleles are indicated at
right. Approximately 5% of total R1- and AB1-derived / ES cells
that passed the high G418 selection exhibited physical signatures
consistent with two targeted PITP alleles as shown. (B) Immuno-
blot analysis of candidate PITP / clones. ES cell strains were
grown to confluence on gelatin-coated tissue culture dishes, har-
vested, and lysed by repeated trituration through a tuberculin sy-
ringe (Pierce Chemical). A sample load of 150 g of total cell lysate
was resolved by SDS-PAGE, and displayed proteins were trans-
ferred to nitrocellulose membranes. Membranes were decorated
with PITP-specific antibodies and developed with horseradish
peroxidase-conjugated secondary antibodies and enhanced chemi-
luminescence detection (Amersham Biosciences). PITP genotypes
are indicated at top. Chicken antibodies specific for PITP were
raised against a peptide corresponding to the C-terminal 15 PITP
amino acids. (C) Measurements of PITP levels. Top, an immuno-
blot experiment performed as described in A with 150 g of total
cell lysate per lane and PITP-specific antibodies as probe. The
PITP-specific antibodies were rabbit polyclonal antibodies directed
against the C-terminal 18 residues of this protein and were gener-
ously provided by Bruce Hamilton (University of California, San
Diego, CA). PITP genotypes are indicated at top. Bottom, quanti-
tative ELISA assay (see MATERIALS AND METHODS) was used to
measure levels of PITP in isogenic PITP /, /, and / ES
cell lines (left, PITP genotype indicated at bottom). For compari-
son, the signals recorded for the indicated amounts of PITP C-
terminal peptide against which the PITP-specific antibodies were
raised is given (right).
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lines provided cells remain viable when challenged with
PITP deficiency.
To determine whether ES cells tolerate loss of PITP, three
of the / R1 ES cell lines and two of the / AB1 ES cell
lines were challenged with a high concentration of G418 (2
mg/ml) in attempts to convert PITP::neo to a homozy-
gous state. Surprisingly, we recovered survivors from the
high G418 selection that bore the genetic signatures of /
ES cells. Of the 98 and 72 / R1 and AB1 ES cell-derived
cell lines that passed the 2 mg/ml G418 selection, 6 and 3
clones exhibit Southern hybridization profiles diagnostic of
a homozygous PITP::neo genotype (Figure 2A). The au-
thenticity of these / clones was confirmed by immuno-
blotting by using an isoform-specific PITP antibody. No
PITP antigen is detected in the candidate / ES cell lines
(Figure 2B).
Quantitative ELISA experiments indicated that PITP and
PITP constitute 0.065 and 0.060% of total ES cell protein,
respectively (our unpublished data). We therefore consid-
ered the possibility that expression of the closely related
PITP may increase in PITP / ES cells as a compensa-
tory mechanism for loss of PITP function. Immunoblotting
experiments indicate that PITP expression is not increased
in PITP / ES cells (Figure 2C), and quantitative ELISA
experiments independently confirm that PITP levels are
comparable in PITP /, /, and / ES cells (Figure
2C). Thus, PITP expression is not increased in PITP /
cells as part of some adaptive response to PITP deficiency.
Finally, analysis of chromosome spreads demonstrated that
the both the R1- and AB1-derived PITP / ES cell lines
harbor the normal murine diploid count of 40 chromosomes
(our unpublished data), indicating that aneuploidy is not
associated with survival of PITP / ES cells. We con-
clude that PITP is nonessential for ES cell viability.
Choline Phospholipid Metabolism in PITP-
deficient Cells
Functional analyses of yeast Sec14p reveal a role for this
protein in regulating the interface between PtdCho metab-
olism and Golgi function (Cleves et al., 1991b; Skinner et al.,
1995; Xie et al., 1998, 2001). A role for PITP in regulating
metabolism of choline phospholipids in mammalian cells
has also been proposed. Antisense approaches suggest that
modest reductions in PITP levels result in significant alter-
ations in PtdCho and SM metabolism in one breast cancer
cell line (Monaco et al., 1998).
To test whether PITP regulates choline phospholipid
metabolism, / and / ES cells were radiolabeled to
steady state with [14C]choline, lipids were extracted, and
radiolabeled choline phospholipids were resolved by TLC.
As shown in Figure 3A, there were no significant differences
in steady-state levels of bulk SM or PtdCho between /
and / ES cells. Moreover, intracellular levels of soluble
choline-containing compounds that serve as precursors of
PtdCho synthesized via the CDP-choline pathway were un-
affected by PITP deficiency (Figure 3B).
Bulk Phosphoinositides in PITP-deficient Cells
Speculations regarding the physiological function of PITPs
in mammalian cells have focused on the role of these pro-
teins in regulating phosphoinositide synthesis. To determine
the consequences of PITP deficiency on phosphoinositide
levels in ES cells, isogenic PITP / and / ES cells
were radiolabeled to steady-state with [3H]inositol. The ino-
sitol lipids were then extracted and resolved by TLC.
The steady-state inositol lipid profiles of / and /
ES cells are essentially identical (Figure 4A). As expected,
PtdIns was the major labeled lipid recovered from both
/ and / ES cells (88.7 	 1.1 and 88.4 	 0.7% of
inositol lipid, respectively). No differences were detected in
the steady-state levels of monophosphorylated PtdIns spe-
cies (i.e., combined levels of PtdIns-3-phosphate and PtdIns-
4-phosphate with the latter representing by far the predom-
inant species) in / versus / ES cells (4.7 	 0.8 and
5.4 	 0.6% of inositol lipid, respectively). Similarly, bis-
Figure 3. (A) Bulk PtdCho and SM profiles of PITP / and
/ ES cell lines. ES cells were labeled to steady state with
[14C]choline, and choline-containing phospholipids (SM and Ptd-
Cho) were resolved from water-soluble choline-containing precur-
sors of PtdCho in a two-phase organic/aqueous solvent system. (A)
Choline-containing lipids SM and PtdCho were distinguished by
deacylation of the lipid fraction and separation of the reaction
products by organic/aqueous partitioning in a two-phase system.
SM and deacylated PtdCho (glycerophosphocholine) were resolved
from the organic and aqueous fractions by TLC, respectively (see
MATERIALS AND METHODS). Data are from three independent
experiments, and are presented as percentage of total choline lipid
recovered as SM and PtdCho, respectively, in isogenic PITP /
(black bars) and PITP / ES cell lines (hatched bars). All ES cell
lines exhibited similar incorporation of [14C]choline into phospho-
lipid. (B) Choline-containing biosynthetic precursors of PtdCho in
PITP / and / ES cell lines were resolved by TLC. The data
are given as the contribution of each indicated choline compound to
total water-soluble radioactivity. Cho, choline; Cho-P, phosphoryl-
choline; CDP-Cho, cytidine-diphosphocholine. Values represent av-
erages of three independent experiments, and the solid and hatched
bars represent data from PITP / and / ES cell lines, respec-
tively.
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phosphorylated PtdIns derivatives (i.e., combined levels of
PtdIns-4,5-P2, PtdIns-3,4-P2, and PtdIns-3,5-P2 with PtdIns-
4,5-P2 representing by far the predominant species) were
also indistinguishable in / versus / cells (3.6 	 1.1
and 3.7 	 1.7% of inositol lipid, respectively). These results
were verified by deacylating the inositol lipid fraction and
resolving the glycerophosphoinositide derivatives by anion-
exchange chromatography. No differences in bulk steady-
state levels of PtdIns, PtdIns-3-phosphate, PtdIns-4-phos-
phate, or PtdIns-4,5-P2 were observed (Figure 4B).
Moreover, the deacylation data were in quantitative agree-
ment with the TLC data.
To assess rates of phosphoinositide synthesis in PITP
/ and / ES cells, cells were pulse-radiolabeled with
[3H]inositol and radiolabeled inositol lipids were then ex-
tracted, resolved, and quantified. As shown in Figure 4C, the
relative rates of PtdIns, PtdIns-phosphate (primarily PtdIns-
4-phosphate), and PtdIns-4,5-P2 were comparable in these
isogenic ES cell lines. To compare efficiencies of phospho-
inositide resynthesis in PITP / and / ES cells after
stimulation, cells were radiolabeled with [3H]inositol to
steady state. Radiolabeled cells were then serum starved,
stimulated with serum for various times, and labeled inosi-
tol phospholipids were extracted and quantified. The inosi-
tol phospholipid profiles of isogenic PITP / and /
cell lines as a function of time were again indistinguishable
(our unpublished data). We conclude that there are no major
reductions in rates of phosphoinositide resynthesis in
PITP-deficient ES cells.
Because PITP is concentrated in the nucleus, PITP /
cells might exhibit alterations in nuclear phosphoinositide
levels. To address this issue, a detergent method was used to
purify nuclei from isogenic / and / ES cells labeled
to steady state with [3H]inositol. Nuclear phosphoinositide
levels were then analyzed. Again, we were unable to discern
any significant differences in the identities of nuclear phos-
phoinositide species or in their steady-state levels between
/ and / ES cells (our unpublished data). These data
indicate that PITP deficiency does not manifest itself in
discernible changes in steady-state levels of either bulk
membrane or nuclear phosphoinositide pools.
Bulk Signaling in PITP-deficient Cells
Although the steady-state data suggest that PITP does not
play a quantitatively obvious role in regulating bulk or nuclear
phosphoinositide pools, these measurements are potentially
insensitive to regulated fluctuations in specific pools. In that
regard, PITP is proposed to be a critical regulator of the
metabolism of PIP pools that sustain signaling via receptors
localized at the plasma membrane (Kauffmann-Zeh et al., 1995).
Thus, we used several independent assays to measure respon-
siveness of / and / ES cells to serum stimulation. First,
isogenic ES cells were labeled to steady state with [3H]inositol,
cells were serum starved, and serum-deprived cells were stim-
ulated with either undialyzed serum or lysophosphatidic acid.
Inositol-1,4,5-trisphosphate was resolved and quantified from
samples collected at various times poststimulation. These time
course experiments failed to reveal obvious differences in bulk
inositol-1,4,5-trisphosphate metabolism in / ES cells rela-
tive to isogenic / cells (our unpublished data).
A second independent approach involved monitoring
evoked Ca2 mobilization in cells. We measured no signif-
Figure 4. Steady-state levels of inositol phospholipids. (A) ES cells were
labeled to steady state with [3H]inositol, and phospholipids were extracted
and resolved by TLC (see MATERIALS AND METHODS). A represen-
tative chromatogram is given (right) with identification of lipid species
(left) and PITP genotype (top). At left are given the quantitative data
obtained from the average of three independent experiments. (B) ES cells
were labeled to steady state with [3H]inositol, phosphoinositides were
extracted, deacylated in the presence of methylamine, and the correspond-
ing glycerophospho-derivatives were resolved by anion exchange chro-
matography (Stolz et al., 1998). The left panel presents the deacylated
PtdIns data for PITP / (solid bars) and / cells (hatched bars),
whereas the right panel shows data for deacylated PtdIns-3-P, PtdIns-4-P,
and PtdIns-4,5-P2. All values represent averages of at least three indepen-
dent experiments. (C) ES cells were pulse radiolabeled for 1 h with 100
Ci/ml of [3H]inositol. Lipids were extracted and resolved by TLC, iden-
tified by autoradiography, scraped, and quantified by scintillation count-
ing. Data are expressed as percentage of total lipid [3H]inositol incorpo-
rated into each lipid species identified at bottom. Values from PITP /
(solid bars) and / cells (stippled bars) are given. PtdIns-P represents
the sum of PtdIns-4-P and PtdIns-3-P values. Data represent the averages
of three independent experiments.
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icant difference between / and / ES cells in the
overall increase in cytosolic Ca2 when serum-deprived
cells were stimulated with 10% serum. Under these stimu-
lation conditions, virtually all of the cells imaged responded
to serum by rapidly increasing cytosolic Ca2 to levels 2.5-
fold greater than those recorded for resting cells (Figure 5).
Because stimulation with high serum might saturate cell
surface receptors, and thereby obscure more subtle signaling
defects in / cells, we repeated the experiments using a
3% serum stimulation. As seen in Figure 5, this low-serum
condition represents a suboptimal stimulation as the ampli-
tude of the response was reduced relative to that scored for
the 10% serum condition. Moreover, only 30% of the wild-
type cells responded to the low-serum stimulus. Yet, even
under these conditions, the latency of the Ca2 response, the
number of cells responding to the serum stimulus, and the
response amplitude were all comparable for / and /
ES cells. Similar results were obtained when serum-deprived
cells were stimulated with LPA alone (our unpublished
data). The data indicate that PITP is dispensable for bulk
cellular responses to serum stimulation, and that plasma
membrane signaling through at least the LPA receptor is
unaffected by PITP deficiency.
Constitutive Secretory Pathway Function in PITP-
deficient Cells
The availability of isogenic / and / cell lines allowed
a survey of the involvement of PITP in defined cellular
functions. Several lines of evidence obtained from biochem-
ical reconstitution systems suggest that PITP regulates con-
stitutive pathways for membrane trafficking through the
Golgi complex (Paul et al., 1998), and from the trans-Golgi
network to the cell surface (Jones et al., 1998). To assess
constitutive secretory pathway function in PITP-deficient
cells, we monitored the synchronized transport of the mu-
tant vesicular stomatitis virus glycoprotein (VSV-G) tsO45
protein from the endoplasmic reticulum (ER) to the Golgi
complex and the cell surface. Incubation of both / and
/ cells at 39.5°C results in accumulation of core glycosy-
lated VSV-G tsO45 in the ER (Aridor and Balch, 1996). Chase
of VSV-G tsO45 from the ER was initiated by addition of
cycloheximide to cells and shifting the infected cells to 32°C
to permit proper folding of the mutant protein.
In both / and / cells, 35% of the VSV-G tsO45
was exported from the ER to the Golgi complex by 15 min of
chase at 32°C as scored by the remodeling of VSV-G glycosyl
chains to a form where these are resistant to endoglycosi-
dase H (EndoH) treatment (Figure 6). By 45 and 60 min of
chase, 50% of the VSV-G tsO45 had acquired EndoH resis-
tance in the / and the / cells (Figure 6). Longer chase
Figure 5. Bulk signaling properties of PITP / and / cells.
ES cells were serum starved for 2 h, loaded with fura 2, and
stimulated with serum (3 or 10%). Ratios of fura 2 excitation at 340
and 380 nm were determined and converted to absolute calcium
concentrations. These concentrations are presented as a function of
serum concentration used to stimulate cells (top) and PITP geno-
type (bottom). Values represent the averages and SDs of cytosolic
Ca2 concentrations measured for 69 PITP / and 67 PITP
/ cells in the 10% serum stimulation condition, and 48 PITP
/ and 45 PITP / cells in the 3% serum stimulation condi-
tion, respectively.
Figure 6. Trafficking of VSV-G from the ER to me-
dial-Golgi in PITP / and / cells. The mutant
VSV-G tsO45 protein was accumulated in the ER of
infected cells (genotypes at left) at 39.5°C and chase
was initiated by adding cycloheximide and reducing
culture temperature to 32°C (t 
 0 min). VSV-G
tsO45 was chased from the ER for various times
(top). Samples were collected and either challenged
with endoglycosidase H () or not () as indicated
at bottom. EndoH resistance signifies arrival in me-
dial-Golgi, and the fraction of EndoH-resistant
VSV-G tsO45 increases with chase. EndoH sensitiv-
ity is scored by increased migration of VSV-G tsO45
after EndoH challenge. Quantification of the fraction
of VSV-G tsO45 that has acquired EndoH resistance
at each time point is given at bottom. One set of
quantifications is given because values were essen-
tially identical for / and / cells.
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times did not result in additional export of VSV-G tsO45
from the ER (our unpublished data). The 50% efficiency of
VSV-G tsO45 export from the ER is in agreement with values
reported by others (Bi et al., 1997). These data indicate that
VSV-G tsO45 transport from the ER to the medial-Golgi (i.e.,
where EndoH resistance is acquired) occurs with similar
kinetics and efficiencies in / and / cells. Surface
labeling methods with VSV-G antibodies revealed robust
plasma membrane labeling in intact / and / cells
within 30 min of release of the 39.5°C block (our unpub-
lished data). The surface-labeling data, although qualitative,
suggest that the rates of VSV-G tsO45 transit from the ER to
the cell surface are similar in PITP / and / cells.
Constitutive Pathways for Endocytosis Operate
Normally in PITP / ES Cells
Operation of the constitutive endocytic cycle is strongly
perturbed by agents such as wortmannin that inhibit path-
ways for synthesis of 3-phosphorylated inositol lipids and
inositides (Corvera et al., 1999). We therefore tested whether
PITP deficiency compromises endocytic pathway activity.
In these experiments, we used the constitutively recycling
TfR as a sensitive reporter for function of the endocytic
pathway in / and / ES cells. Because TfR is a long-
lived protein that recycles rapidly through the endosomal
pathway, even subtle defects in TfR internalization from the
cell surface, or in TfR recycling from endosomes back to the
cell surface, exert large effects on steady-state TfR distribu-
tion. Using an 125I-transferrin binding assay to register sur-
face-exposed TfR, we found that the steady-state distribu-
tions of TfR are similar in / and / cells irrespective of
whether cells are incubated in 10 or 3% serum. In all cases,
60% of the TfR is present in intracellular compartments,
whereas 40% of the TfR resides at the cell surface (Figure
7A). These steady-state distributions of TfR are in close
agreement with those recorded for other cell types (Jing et
al., 1990; Cotlin et al., 1999).
The normal TfR distribution between the plasma mem-
brane and intracellular pools in / ES cells suggests either
that rates of TfR internalization and recycling are unadul-
terated in PITP-deficient cells, or that any alterations in
internalization or recycling rates are compensated by alter-
ations in the opposing arm of the TfR trafficking pathway.
To measure TfR internalization rates (expressed as kin), we
used the IN/SUR method to monitor the rate at which
surface 125I-transferrin–TfR complexes acquired resistance
to surface stripping with a low-pH wash. As shown in
Figure 7B, / cells exhibit a kin 
 0.123 	 0.075 when
incubated in 10% serum and 0.125 	 0.064 when the assay is
performed in cells cultured in 3% serum. Similarly, TfR kin
values are 0.129 	 0.078 and 0.133 	 0.042 in / cells
incubated in 10 and 3% serum, respectively. Thus, PITP
deficiency does not impose a defect on rate of TfR internal-
ization into cells.
Finally, the data show that the rate of TfR recycling from
intracellular compartments to the cell surface is also refrac-
tory to PITP dysfunction. By monitoring the rate at which
internalized 125I-transferrin–TfR complexes reach the cell
exterior, rates of TfR recycling (kext) in / and / cells
were calculated. The recycling rates are essentially the same
Figure 7. (A) Steady-state distribution of
TfR on the cell surface of PITP / and
/ cells. Steady-state distribution of TfR
was performed as described previously at
37°C (Odorizzi et al., 1994; see MATERIALS
AND METHODS) with the modification that
PITP / and / ES cells were plated in
triplicate in standard media containing either
10 or 3% serum. The percentage of total
125I-Tf (and therefore TfR) located at the cell
surface (solid bars) and within the cell
(hatched bars) is given for each ES cell PITP
genotype (/ or /; bottom) and for
each serum concentration tested (3 and 10%;
top). (B) Kinetics of TfR internalization and
recycling in PITP / and / cells. For
internalization assays, PITP / (solid
bars) and / cells (hatched bars) were pre-
incubated in serum-free media at 37°C and
prewarmed 125I-Tf was added for various
times up to 10 min. At each time point, the
ratio of internalized and surface 125I-Tf was
distinguished by an acid strip of the cell sur-
face, and Tf(internal)/Tf(surface) ratio was
plotted as a function of time. The slope of
each curve yields the TfR internalization con-
stant kin, and the data represent the mean and
SDs derived from at least three independent
determinations. To measure the recycling constant kext, cells were incubated with 125I-Tf for 1 h at 37°C and chilled. Surface-bound 125I-labeled
Tf was removed by chelation with deferosamine at 4°C, cells were warmed to 37°C to initiate chase of 125I-Tf from endocytic compartments
to the cell surface, and measurements of cell-associated and -released radioactivity were taken at various times of chase. The Tf(secreted)/
Tf(internal) ratio was plotted against time, and the slope of each curve yields kext. The data represent the mean and SE derived from at least
three independent determinations.
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Figure 8. (A) Expression of IgE binding sites on the
surface of / and isogenic PITP / ES cells
during phase 2 culture. Cells were treated with FITC-
labeled IgE (5 nM) and surface IgE-FITC was quanti-
fied by flow cytometry. Shaded histograms represent
populations from phase 2 cultures with ages in days
indicated at right. Results from / cells are in the
right-hand panels. Control cells (open histograms) rep-
resent passage-matched cells maintained for the same
period exclusively in phase 1 medium. Results are
representative of three independent experiments. (B)
Mast cells from isogenic PITP / and / ES cells
(genotype at top) were visualized by thin-section elec-
tron microscopy. Magnifications for each panel are
given. PITP / and / ES cells yielded mast
cells packed with morphologically correct dense core
secretory granules.
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in / and / cell lines irrespective of whether cells are
incubated at 3% serum (kext 
 0.085 	 0.007 vs. 0.085 	 0.007
min1) or 10% serum (kext 
 0.075 	 0.021 vs. 0.080 	 0.028
min1; Figure 7B). These collective data indicate that the
constitutive endocytic cycle operates normally in PITP-
deficient cells.
Regulated Exocytosis in PITP-deficient Mast Cells
Because PITP has been implicated in catalyzing formation
and priming of secretory granules for agonist-induced exo-
cytosis (Hay and Martin, 1993; Ohashi et al., 1995; Fensome
et al., 1996; Pinxteren et al., 1998, 2001), we investigated the
consequence of PITP deficiency to the activity of the regu-
lated exocytotic pathway in ES cell-derived mast cells. Ini-
tially, we tested whether / ES cells could be induced to
become functional mast cells. We subjected isogenic /
and / ES cell lines to conditions that induce ES cells to
differentiate into the mast cell lineage (see MATERIALS
AND METHODS). At various times during a 40-d period of
maturation in phase 2 medium, the differentiating cell cul-
tures were harvested and subjected to two tests for acquisi-
tion of mast cell properties. First, FACS was used monitor
expression of FcRI, a mast cell marker, on the cell surface.
Second, we used to electron microscopy to visualize forma-
tion of mast cell-like DSGs in the differentiating cell popu-
lation. Mature cells (30 d in phase 2) were then used in
established assays that measure secretory capacity directly.
As shown in Figure 8A, both / and / ES cells
express the high-affinity receptor for IgE (FcRI) equally well
and the efficiency of differentiation to mast cells is depen-
dent on the length of culture incubation in phase 1 medium.
The optimum incubation was 9 d, with 75–80% of the cells
expressing FcRI after 35 d in phase 2 (Figure 8A, bottom).
Shorter or longer periods in phase 1 medium gave a lower
yield of mast cells, e.g., 50% (5 d) and 58% (21 d). No further
increase in the expression of FcRI was observed after 35 d
in phase 2 (our unpublished data).
Visualization of differentiated cell populations by electron
microscopy confirmed that both / and / ES cells
efficiently manufacture DSGs, and that these granules are
morphologically indistinguishable from those present in au-
thentic mast cells. In cells derived from both / and /
lineages, the mast-like cells were packed with DSGs (Figure
8B). Classification of these granules as DSGs is further sup-
ported by the demonstration that the granule-bearing cells
express both the mast cell-specific marker tryptase and his-
tamine. By these criteria, 80% of the / and / ES
cells adopted the morphological characteristics of mast cells.
We conclude that both DSG biogenesis and mast cell differ-
entiation proceed efficiently in the face of PITP deficiency.
To characterize the secretory competence of these differ-
entiated cells, we stimulated intact cells to exocytose. Both
/ and / ES cell-derived mast cells are perfectly able
to secrete granule contents after loading of the cell surface
with anti-DNP IgE and stimulating the loaded cells with a
DNP-conjugated human serum albumin agonist (Table 1).
These data demonstrate that the physiologically relevant
regulated exocytotic machinery is in place in PITP-deficient
cells.
Rundown in Permeabilized PITP-deficient Mast
Cells
Agonist-induced exocytotic events have been reconstituted
in permeabilized mast cells, and this reaction exhibits “run-
down.” Rundown is the progressive decrease in exocytotic
efficiency that is recorded as the time interval between cell
permeabilization and addition of secretory stimulus in-
creases, and reflects the progressive destruction of phos-
phoinositides in the permeabilized cell ghosts (Pinxteren et
al., 1998, 2001). Addition of either cytosol or purified PITP
to the permeabilized cells strongly diminishes rundown
rate, suggesting that PITP may represent the key cytosolic
factor that stimulates the reconstituted exocytotic event
(Pinxteren et al., 1998, 2001).
Figure 8. Continued.
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If PITP is indeed a major factor in synthesis of phospho-
inositide pools required for agonist-induced exocytosis, sig-
nificant differences in the rates of rundown in permeabilized
PITP / versus PITP / mast cells should be appar-
ent. As shown in Table 2, application of 100 M guanosine-
5-O-(3-thio)triphosphate at pCa5 to SLO-permeabilized
peritoneal mast cells or to / and / ES cell-derived
mast cells elicited the massive degranulation normally re-
corded upon such treatment, and the corresponding values
recorded for each cell type were set at 100%. As reported
previously (Pinxteren et al., 1998, 2001), the exocytotic effi-
ciency recorded for peritoneal mast cells was inversely pro-
portional to time of preincubation of permeabilized cells
before stimulation. This rate of peritoneal mast cell rundown
closely resembles that measured for permeabilized PITP
/ ES cell-derived mast cells. These data further demon-
strate that ES cell-derived mast cells exhibit the properties of
genuine mast cells. Rundown in the PITP-deficient system
was not accelerated relative to the peritoneal mast cell and
PITP / ES cell-derived mast cell controls (Table 2).
These data indicate that PITP is not a major factor in the
resynthesis of phosphoinositide pools whose integrity is
scored in the reconstituted reaction. It remains possible that
PITP is the physiological PITP isoform that is dedicated to
this reaction. Quantitative ELISA experiments indicated that
PITP is more abundant in mast cells than is PITP (our
unpublished data).
Growth and Pluripotency of PITP-deficient ES
Cells in Nude Mice
PITP-deficient ES cells are robust by the definition that
such cells exhibit wild-type growth rates in culture when
presented with a range of fetal calf serum concentrations (15,
10, and 3%; our unpublished data). We considered the pos-
sibility that / ES cell lines might exhibit growth defects
when placed into an environment where these cells must
compete vigorously with wild-type cells for growth factors.
To this end, isogenic R1-derived / and / ES cell lines
and isogenic AB1-derived / and / ES cell lines were
introduced into adult athymic nude mice via a subcutaneous
injection route. The abilities of these ES cell lines to form
tumors in nude mice were then quantified.
In all cases, palpable tumors were produced within 3 wk
of injection, and no significant differences were recorded
between / and / ES cell lines with regard to average
size of tumors (Table 3). In the R1 ES cell genetic back-
ground, all seven mice injected with / ES cells elabo-
rated tumors with an average tumor mass of 0.88 	 0.56 g.
Similarly, all 10 mice injected with / cells elaborated
tumors, and these tumors exhibited a mass of 0.86 	 0.43 g.
Table 1. IgE-dependent secretion from peritoneal mouse mast cells and ES cell-derived mast cells
The values (%) express the secretion (	 SEM, n 
 4 separate determinations) elicited by applying human serum albumin-DNP to anti-DNP
IgE-loaded cells at the indicated concentrations and under the conditions as described in MATERIALS AND METHODS. Genotypes of the
cells are indicated at left. Authentic peritoneal mast cells (PMCs) were us as positive controls and were isolated by peritoneal lavage of
2–10-wk-old male C57 Bl/6J mice. Mast cells were purified (95%) by centrifugation through a Percoll cushion, essentially as previously




0 1 10 100 0 1 10 100
PMCs 1.1 	 0.3 19.6 	 1.8 21.1 	 1.8 20.5 	 1.4 2.2 	 0.7 11.2 	 2.7 11.4 	 1.5 12.9 	 2.4
/ 1.5 	 0.2 19.6 	 2.0 18.8 	 0.7 19.5 	 2.8 0.7 	 0.2 11.2 	 1.3 9.0 	 2.1 8.7 	 0.7
/ 1.2 	 0.4 18.6 	 1.7 20.0 	 1.4 20.2 	 2.3 0.9 	 0.5 10.5 	 0.9 10.2 	 0.9 10.5 	 0.4
Table 2. Secretion from permeabilized peritoneal- and ES cell-de-
rived mast cells
Peritoneal mast cells (PMCs; isolated as described in the legend to
Table 1) and isogenic / and / ES cell-derived mast cells,
pretreated with SLO at 0°C were permeabilized by transfer to a
buffer (pH 6.8) containing 1 mM MgATP and 0.1 mM EGTA to
reduce free [Ca2] to below 108M. This treatment induces a time-
dependent rundown of secretion efficiency that is a function of
progressive loss of a phosphoinositide pool required for the exocy-
totic event (Pinxteren et al., 1998, 2001). At the indicated rundown
times, cells were stimulated by a secretagogue cocktail containing
100 M GTPS and 3 mM Ca-EGTA formulated to regulate pCa5.
After a 10-min incubation, the systems were quenched with an
ice-cold salts buffer containing 5 mM EGTA. The cells were sedi-
mented and the supernatants were sampled and assayed for se-
creted hexosaminidase. Data points (%) represent mean values 	
SEM (n 
 4) normalized to maximum secretion (100%) determined
in absence of rundown (time 0). PMCs serve as positive control.
Time of rundown 0 min 2 min 10 min 30 min
PMCs 100 57.7 	 2.8 25.3 	 2.0 2.6 	 0.3
/ 100 55.7 	 12.1 23.7 	 3.0 4.0 	 1.5
/ 100 51.2 	 3.6 22.6 	 3.1 2.6 	 1.1
Table 3. Tumorigenic potential of PITP / and / ES cells
Athymic nude mice were injected subcutaneously in the hind
flank with 107 ES cells suspended in 0.2 ml of PBS/glucose. The
tumors that formed were surgically harvested after 3 wk and
weighed. Values represent the mean and standard error derived






R1 PITP / 7/7 0.88 	 0.56
R1 PITP / 10/10 0.86 	 0.43
AB1 PITP / 4/4 1.27 	 0.13
AB1 PITP / 10/10 1.48 	 0.45
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Consistent results were obtained when / and / ES
cells of the AB1 genetic background were analyzed. The
average tumor mass measured from four independent /
AB1-derived ES cell experiments was 1.27 	 0.13 g. Two
separate experiments, each involving the injection of five
mice with isogenic AB1-derived PITP / ES cells,
yielded average tumor masses of 1.66 	 0.36 and 1.28 	
0.55g, respectively (Table 3). Thus, PITP deficiency does
not compromise either R1 or AB1 ES cell vigor when this
property is assayed in a physiological context.
Finally, no obvious distinctions were apparent between
the histology of tumors derived from / and / ES cell
lines. Tumors from both genetic backgrounds represented
complex teratomas consisting of neural, respiratory, muscle,
gastrointestinal, developing spinal chord, and collagenous
tissues. Moreover, inner masses of / ES cell-derived
tumors often exhibit complex structures, e.g., glandular
structures lined with ciliated epithelia (our unpublished
data). Thus, PITP deficiency fails to compromise ES cell
vigor and is of no obvious consequence for ES cell differen-
tiation into multiple lineages and into intricate multicellular
structures. The fundamental dispensability of PITP for mu-
rine development is confirmed by our finding that PITP
/ mice are born alive at standard Mendelian frequencies
(Alb and Bankaitis, unpublished data).
Targeting of PITP Mutation into Murine
Embryonic Stem Cell Genome
The dispensability of PITP for housekeeping functions in
murine cells is consistent with the possibility that PITP and
PITP are largely redundant and contribute rather equally to
essential housekeeping functions. Alternatively, PITP might
represent the essential mammalian housekeeping PITP,
whereas PITP serves a very specific and as-yet-unidentified
function. We therefore used gene-targeting methods to assess
the cellular consequences of PITP dysfunction. We isolated a
5-kb fragment of 129SVJ mouse genomic DNA that harbors
three exons of the PITP gene. These exons encode amino acids
66–121 of the 278 residue PITP polypeptide, and the homol-
ogous recombination vector derived from this fragment carries
a mutant PITP allele where exons A and B are replaced with
a neo cassette (Figure 9A). This mutation (PITP::neo) de-
letes residues 66–99 from PITP. Based on our functional anal-
yses of PITP (Alb et al., 1995), PITP::neo almost certainly
represents a null mutation.
The targeting vector was linearized and electroporated
into murine ES cell lines derived from the AB1 mouse strain.
Recombinants were again selected using a selection for re-
combinants exhibiting dual resistance to neomycin and
gangcyclovir. Of clones that survived the double selection,
50 were screened for legitimate recombination events. One
ES cell line exhibited the genetic signatures of a
PITP::neo/ heterozygote (Figure 9B). We challenged
this cell line with high G418 in an attempt to generate PITP
/ ES cells and recovered 150 clones resistant to high
concentrations of G418. In contrast to the results obtained
with PITP / ES cells, genotypic analysis of these G418-
resistant ES cell clones failed to identify PITP / ES cell
clones (our unpublished data).
Consequences of PITP Deficiency in Mice
Our failure to recover PITP / ES cells via the high G418
resistance selection may be the direct consequence of ablating
an essential activity of PITP at the cellular level, or may
simply reflect some trivial difficulty in obtaining such clones
that is unrelated to loss of PITP function. If PITP is the sole,
or even the major, executor of an essential cellular function,
PITP deficiency should manifest itself in an early embryonic
lethal phenotype. If PITP is not an essential cellular house-
keeping PITP then PITP / mice should exhibit significant
developmental progress before failure is realized. To distin-
guish these possibilities, the PITP::neo allele was passed
through the murine germline and a colony of PITP / mice
was generated (see MATERIALS AND METHODS). We then
analyzed the F1 progeny generated by intercross of PITP
/ heterozygotes for / mice or embryos. From a set of
166 live births we recovered a ratio of 58 /:108 / F1
progeny that closely conformed to the 1:2 ratio predicted by
Mendel’s rules (Figure 9C). Yet, we failed to recover any /
progeny in the F1 at all. Equal numbers of / and / F1
progeny are expected if PITP deficiency is not associated with
a cell- or embryonic-lethal phenotype. Thus, PITP / mice
do not survive to term.
To further assess the consequences of PITP deficiency for
murine development, we performed a series of timed mat-
ing experiments and surveyed a total of 79 F1 embryos
harvested in an E7.5-E11.5 developmental window. Again, a
Mendelian distribution of 24 /:58 / F1 embryos was
recorded, but no / embryos were recovered in the F1
progeny (Figure 9D). In these experiments, we failed to
detect any unusual signs of embryo resorption. These data
indicate that PITP deficiency minimally results in early
embryonic lethality of the developing mouse.
DISCUSSION
Genetic experiments in yeast have demonstrated that spe-
cific PITPs, such as the budding and fission yeast Sec14ps,
execute essential cellular housekeeping functions (Bankaitis
et al., 1989, 1990; Nakase et al., 2001). Other PITP isoforms,
such as the nonclassical SFH PITPs of S. cerevisiae and the
one known Sec14p of the dimorphic yeast Yarrowia lipolytica,
perform specific nonessential functions (Lopez et al., 1994; Li
et al., 2000; Wu et al., 2000). The genetic approaches used in
studies of yeast PITP function, and also in the function of a
nonessential Drosophila PITP (Milligan et al., 1997), have
revealed striking specificities of physiological function.
These specificities, at least to this point, have been invisible
in the in vitro systems used to study mammalian PITP
function (reviewed in Kearns et al., 1998).
Herein, we report the outcome of genetic experiments that
for the first time characterize the physiological consequences
associated with functional ablation of PITP and PITP
isoforms in murine ES cells. Our results clearly demonstrate
that, in two distinct ES cell lines, specific genetic ablation of
PITP function does not compromise ES cell viability. De-
tailed analyses of inositol- and choline-phospholipid metab-
olism failed to reveal any significant aberrations in PITP-
deficient cells. In this regard, our data do not support a
previous report that PITP is required for normal metabo-
lism of PtdCho and SM in living cells (Monaco et al., 1998).
The data also fail to support proposals, based solely on
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overexpression data, that PITP plays a major physiological
role in stimulating deacylation of PtdIns to lyso-PtdIns in
vivo (Snoek et al., 1999).
Of special note was the surprising indifference of bulk
phosphoinositide metabolism to loss of PITP function. Al-
though interpretations of bulk lipid analyses are subject to
the caveat that PITP may play a significant role in synthe-
sis/maintenance of a phosphoinositide pool(s) that makes
only a quantitatively minor contribution to the bulk mem-
brane phosphoinositide content, our present in vivo data fail
to reveal the existence of such a PITP-dependent pool. For
example, we have not detected enhanced sensitivity of
PITP / cells to inhibitors of phosphoinositide synthesis
such as wortmannin (our unpublished data). Moreover,
PITP deficiency has no significant effect on the activity of
cellular functions that have documented phosphoinositide
requirements. These include 1) constitutive protein traffick-
ing, 2) internalization of TfR from the plasma membrane and
its recycling from endocytic compartments back to the cell
surface, and 3) the biogenesis and agonist-induced fusion of
DSGs with the mast cell plasma membrane. In addition, no
deficiencies in growth factor signaling were evident either in
PITP / cells stimulated in culture, or in efficiency of
tumor formation in vivo. Thus, PITP-deficient ES cells com-
pete robustly for growth factors in situ, these cells respond
normally to growth factors in the competitive context of the
whole animal, and the pluripotency of ES cells is not com-
promised by loss of PITP function. Finally, the dispensabil-
ity of PITP for cell viability and fetal murine development
is amply demonstrated by our finding that PITP / mice
Figure 9. (A) Targeting the PITP locus. A 5-kb
SacI-SacI genomic fragment was excised from a
cloned 15-kb genomic DNA fragment and deter-
mined to carry three PITP exons (designated A, B,
and C) that encode residues 66–152 of the mouse
PITP. Southern analyses of the adjacent 10-kb
genomic fragment did not reveal any exons. From
this 10-kb DNA, a 4-kb SacI/EcoRV fragment that
lies adjacent to the 5-kb SacI-SacI genomic DNA was
cloned to generate a cassette containing 9 kb of total
homology to the PITP. Exons A and B were re-
placed with a neo cassette described in Figure 1A,
and HSV-tk was introduced at one end of the cloned
PITP DNA. The targeting vector was linearized,
introduced into ES cells by electroporation, and re-
combinants that acquire resistance to both G418 and
gangcyclovir were selected. Positions of probes 1
and 2 for diagnosis of wild-type and targeted PITP
alleles by Southern hybridization are shown. In hy-
bridization experiments, EcoRV digestion was rou-
tinely used as a diagnostic. The wild-type PITP
locus generates a 10.5-kb EcoRV restriction frag-
ment, and the ends of this fragment both lie outside
the targeting region. NEO introduces a new EcoRV
site into the PITP locus so that the targeted allele
yields an 8.0- and a 2.7-kb fragment revealed with
probes 1 and 2, respectively. (B) Distribution of
PITP genotypes in the F1. The 78 live-born F1
progeny analyzed from intercross of PITP /
mice were scored by PCR. The positions of the three
primers for PCR diagnosis of wild-type and targeted
PITP alleles are shown. The wild-type allele was
diagnosed using primer 1 (PITP-1045-R; 5-GC-
GAACAACCTGTGAGCC CAG-3) and primer
2 (PITP-545-F; 5-GTGAACAAGTACCAGCAGC-
GC-3). The PITP null allele was diagnosed using
primer 1 (PITP-1045-R; 5-GCGAACAACCTGTG A-
GCCCAG-3) and primer 3 (3-NEO1; 5-GCCAGA-
GGCCACTTGTGTAGCGCC-3). Polymerase chain
reaction products derived from the wild-type PITP
and targeted PITP alleles are 500 and 225 base
pairs, respectively. The number of live births ob-
tained for each PITP genotype (bottom) is indi-
cated. (C) PITP genotypes in F1 embryos derived
from intercross of PITP / mice. Sixty-six F1
embryos derived from intercross of PITP /
mice were harvested in an E7.5-E11.5 window. The
number of embryos obtained for each PITP geno-
typic class (bottom) is given. Embryos were geno-
typed by polymerase chain reaction as outlined in B.
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develop to term (Alb and Bankaitis, unpublished data).
These mice fail to thrive, however. Detailed analysis of
PITP / mice will be presented elsewhere.
Although the data demonstrate PITP does not signifi-
cantly contribute to essential housekeeping functions in mu-
rine ES cells, our results suggest that PITP does. Starting
with a PITP / cell line, we failed to recover PITP /
ES cells even though we used a positive selection for such
mutants. Although the failure to isolate PITP / ES cells
is by itself a negative result, our demonstrations that PITP
/ mice do not survive to term, and that PITP deficiency
results in early embryonic lethality, are consistent with in-
compatibility of PITP dysfunction with cell viability. The
timing and mechanism of PITP-less lethality in the mouse
remain to be determined.
In closing, the collective data allow us to discard the
possibility that PITP and PITP are perfectly redundant
PITPs that share equal responsibilities in executing essential
cellular housekeeping functions. We are presently left with
two interpretations of the data: 1) PITP is a major PITP
isoform, whereas PITP is a functionally redundant minor
isoform; or 2) PITP and PITP are not functionally redun-
dant PITPs and PITP is a highly specialized isoform dedi-
cated to functions that apply only to very specific cell types.
Demonstrations that PITP and PITP defects evoke strik-
ingly different phenotypic consequences, when coupled
with PITP and PITP being biochemically distinct proteins
that localize to different subcellular compartments (de Vries
et al., 1996; our unpublished data), lead us to favor the
interpretation that PITP and PITP are not functionally
redundant PITPs. We suggest that the PITP is a highly
specialized isoform dedicated to functions that apply only to
very specific cell types, whereas PITP executes essential
housekeeping functions in many cell types. Extension of the
genetic approaches described herein will permit direct tests
of these possibilities, and will contribute to our understand-
ing of PITP and PITP function in mammalian cells.
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